Discovery and optimization of tetrahydropyrido[4,3-d]pyrimidine derivatives as novel ATX and EGFR dual inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery and optimization of tetrahydropyrido[4,3-d]pyrimidine derivatives as novel ATX and EGFR dual inhibitors

Published:2018-05 Issue:8 Volume:26 Page:1784-1796
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Jing Tongfei,Miao Xiuqi,Jiang Feng,Guo Ming,Xing Lingyun,Zhang Junlong,Zuo Daiying,Lei Hongrui,Zhai Xin

Funder

Development Project of Ministry of Education Innovation Team

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference32 articles.

1. Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update;Kakerina;Curr Opin Pulm Med,2015

2. The impact of lung cancer on survival of idiopathic pulmonary fibrosis;Tomassetti;Chest,2015

3. MA05.05 genomic profiles of lung cancer associated with idiopathic pulmonary fibrosis;Hwang;J Thorac Oncol,2017

4. Beta-catenin signaling in fibroproliferative disease;Bowley;J Surg Res,2007

5. Antioxidants as potential therapeutics for lung fibrosis;Day;Antioxid Redox Signal,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review;International Journal of Biological Macromolecules;2023-12

2. An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC);Journal of Biomolecular Structure and Dynamics;2023-08-29

3. Synthesis and Anti-Toxoplasma Activity of Novel Tetrahydropyrido[4,3-d]pyrimidine Derivatives;CHEM J CHINESE U;2023

4. Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships;ChemistrySelect;2023-07-10

5. Recent research advances in ATX inhibitors: An overview of primary literature;Bioorganic & Medicinal Chemistry;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3